Sumitomo Mitsui Trust Group Inc. reduced its position in Burning Rock Biotech Limited (NASDAQ:BNR – Free Report) by 4.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 51,639 shares of the company’s stock after selling 2,664 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.50% of Burning Rock Biotech worth $349,000 as of its most recent filing with the SEC.
Burning Rock Biotech Trading Up 13.0 %
Shares of Burning Rock Biotech stock opened at $6.94 on Friday. Burning Rock Biotech Limited has a 1-year low of $2.62 and a 1-year high of $8.99. The company has a 50 day moving average of $6.73 and a 200-day moving average of $5.30. The company has a market cap of $71.07 million, a PE ratio of -2.31 and a beta of 0.55.
Burning Rock Biotech (NASDAQ:BNR – Get Free Report) last issued its earnings results on Tuesday, December 3rd. The company reported ($0.50) earnings per share (EPS) for the quarter. Burning Rock Biotech had a negative return on equity of 60.68% and a negative net margin of 83.50%.
About Burning Rock Biotech
Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples.
Recommended Stories
- Five stocks we like better than Burning Rock Biotech
- 10 Best Airline Stocks to Buy
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- What Are Earnings Reports?
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Want to see what other hedge funds are holding BNR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Burning Rock Biotech Limited (NASDAQ:BNR – Free Report).
Receive News & Ratings for Burning Rock Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burning Rock Biotech and related companies with MarketBeat.com's FREE daily email newsletter.